Transgene Biotek Ltd

TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half yearly ended on September 30 2024.2) To consider and approve the Limited Review Report (Standalone & Consolidated) for the quarter and half yearly ended on ended September 30 2024.3) To consider and approve the Notice of the 34th Annual General Meeting for the financial Year 2023-24 and other related matters thereto.4) To consider and approve Directors Report and the annexure thereon for the financial year 2023-24.5) To fix Record Date Book Closure date and E voting dates etc.6) To Appoint a Scrutinizer for the e voting Process.7) To transact such other business as may be required.